[The effectiveness of adjuvant systemic therapy in organ-preserving therapy of breast cancer]

Autor:	V F, Semiglazov, S V, Kanaev, I L, Bugrova, O L, Chagunava
Rok vydání:	1998
Předmět:	Antineoplastic Agents Hormonal Breast Neoplasms Middle Aged Mastectomy Segmental Survival Analysis Disease-Free Survival Postmenopause Tamoxifen Treatment Outcome Premenopause Chemotherapy Adjuvant Antineoplastic Combined Chemotherapy Protocols Humans Female Neoplasm Staging
Zdroj:	Voprosy onkologii. 44(4)
ISSN:	0507-3758
Popis:	The role of adjuvant therapy in breast-conserving treatment was studied in 360 cancer patients (reproductive, agedor = 55 yrs, and postmenopausal, aged55 yrs) with T1-2N0M0 tumors under 2.5 cm (1985-1996). Mortality rates fell by 17% in postmenopausal patients who received adjuvant therapy (tamoxifen) and by 34%--in the reproductive group after polychemotherapy (CMF) and 36%--after hormonal therapy (tamoxifen).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::368a4b5473c8d2e7df25b2efa6585f38 https://pubmed.ncbi.nlm.nih.gov/9807203 Zobrazit plný text záznamu